Arrowstreet Capital’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $685K | Sell |
102,008
-21,890
| -18% | -$147K | ﹤0.01% | 1684 |
|
|
2025
Q1 | $1.12M | Sell |
123,898
-98,622
| -44% | -$892K | ﹤0.01% | 1447 |
|
|
2024
Q4 | $3.85M | Buy |
222,520
+122,823
| +123% | +$2.12M | ﹤0.01% | 1078 |
|
|
2024
Q3 | $1.59M | Buy |
99,697
+85,390
| +597% | +$1.36M | ﹤0.01% | 1283 |
|
|
2024
Q2 | $204K | Hold |
14,307
| – | – | ﹤0.01% | 1445 |
|
|
2024
Q1 | $203K | Buy |
+14,307
| New | +$203K | ﹤0.01% | 1580 |
|